Harris Associates L P Reduces $28M in Corteva, Inc. ($CTVA)
Key Points
- Harris Associates L P changed its Corteva, Inc. ($CTVA) stake by 2.2% last quarter, cutting to 16,656,133 shares worth $1.25 billion.
- Wall Street's consensus rating on $CTVA is Buy and an average price target of $90.05.
- $CTVA last traded around $74.84.
Harris Associates L P trimmed its position in Corteva, Inc. ($CTVA) by 2.2% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,656,133 shares of Corteva, Inc. after selling 370,088 shares during the quarter. Harris Associates L P's holdings in Corteva, Inc. were worth $1.25 billion as of its most recent filing.
Corteva, Inc. ($CTVA) Stock
Corteva, Inc. Earnings
Corteva, Inc. Dividend
Analysts Set New Price Targets
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.